1. Ding, Chunyong, Song, Zilan, Shen, Ancheng, Chen, Tingting, Zhang, Ao. 2020. Small molecules targeting the innate immune cGAS‒STING‒TBK1 signaling pathway. In Acta pharmaceutica Sinica. B, 10, 2272-2298. doi:10.1016/j.apsb.2020.03.001. https://pubmed.ncbi.nlm.nih.gov/33354501/
2. Lafont, Elodie, Draber, Peter, Rieser, Eva, Linkermann, Andreas, Walczak, Henning. 2018. TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation. In Nature cell biology, 20, 1389-1399. doi:10.1038/s41556-018-0229-6. https://pubmed.ncbi.nlm.nih.gov/30420664/
3. Zhang, Conggang, Shang, Guijun, Gui, Xiang, Bai, Xiao-Chen, Chen, Zhijian J. 2019. Structural basis of STING binding with and phosphorylation by TBK1. In Nature, 567, 394-398. doi:10.1038/s41586-019-1000-2. https://pubmed.ncbi.nlm.nih.gov/30842653/
4. Duan, Qing-Qing, Wang, Han, Su, Wei-Ming, Wang, Yi, Chen, Yong-Ping. 2024. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro. In BMC medicine, 22, 96. doi:10.1186/s12916-024-03314-1. https://pubmed.ncbi.nlm.nih.gov/38443977/
5. Barbie, David A, Tamayo, Pablo, Boehm, Jesse S, Jacks, Tyler, Hahn, William C. 2009. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. In Nature, 462, 108-12. doi:10.1038/nature08460. https://pubmed.ncbi.nlm.nih.gov/19847166/
6. Lin, Yongfang, Yang, Jing, Yang, Qili, Chen, Dahua, Sun, Qinmiao. 2023. PTK2B promotes TBK1 and STING oligomerization and enhances the STING-TBK1 signaling. In Nature communications, 14, 7567. doi:10.1038/s41467-023-43419-4. https://pubmed.ncbi.nlm.nih.gov/37989995/